Cancer

Adults with diabetes and those with more than 50% carotid stenosis are at greater risks for cancer than those without diabetes and those with less than 50% carotid stenosis, according to findings published in Nutrition, Metabolism & Cardiovascular Diseases.

Although the risks for specific cancers and infections were similar between abatacept and other biologic and targeted synthetic DMARDs among patients with rheumatoid arthritis, a slight increase in total cancer risk associated with the drug requires additional research, according to data published in Arthritis Research & Therapy.

Older adults who were hospitalized unexpectedly for the first time faced a 5-fold increased risk for death compared with those who were not hospitalized, according to a study published in CMAJ.

The Society for Endocrinology and the British Thyroid Association issued a joint statement urging caution when interpreting a recent study linking radioactive iodine therapy to cancer mortality among people with hyperthyroidism.

The Society for Endocrinology and the British Thyroid Association issued a joint statement urging caution when interpreting a recent study linking radioactive iodine therapy to cancer mortality among people with hyperthyroidism.

Expanding the current HPV vaccination program in the United States to include men and women up to age 45 years may only produce small additional benefits and is not nearly as cost-effective as it is among younger age groups, according to a study published in the Annals of Internal Medicine.

LOS ANGELES — In this video exclusive, Derek LeRoith, MD, PhD, professor of medicine and endocrinology and director of research in the endocrine division at Mount Sinai in New York, discusses hyperinsulinemia as a risk factor for cancer.

PHILADELPHIA — People at high risk for CVD, as assessed by risk factors, 10-year atherosclerotic CVD risk score and biomarkers, also have elevated risk for cancer, according to research presented at the American Heart Association Scientific Sessions.

Chimeric antigen receptor T-cell therapies have been approved by the FDA for two indications thus far, with a third for multiple myeloma expected sometime next year. James N. Kochenderfer, MD, a physician-scientist in the Surgery Branch of the National Cancer Institute, is one of the few people who can say they have been a part of CAR T-cell development in all three areas that have demonstrated historically high response rates among patients with advanced blood cancers.

ATLANTA — Drugs that have known potential impacts on gut microbiota and are commonly prescribed by rheumatologists can have detrimental impacts on the efficacy of immune checkpoint inhibitors used to treat cancer, according to data presented at the ACR/ARP 2019 Annual Meeting.